Lymphoproliferative Disorders Flashcards

1
Q

Most lymphomas affect lymph nodes to some extend but can effect the whole ____

A

body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is leukaemia?

A

•Generally used to describe a cancer that you can see in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a lymphoma? and how does it present?

A
  • Cancers of lymphoid origin
  • Can present with enlarged lymph nodes (lymphadenopathy)

or

•with extranodal involvement (These cells are blood cells so can go anywhere in the body)

or

  • with bone marrow involvement
  • Systemic (B) symptoms - Weight loss (> 10% in 6 months), fever, night sweats, pruritis, fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosing a lymphoma/ leukaemia - how is it done?

A
  • > 50 different disease entities, defined by the malignant cell characteristics (Not defined by clinical presentation but rather malignant cell characteristics)
  • Biopsy (e.g. lymph node, bone marrow) tells us what type it is – THIS IS HOW THE DIAGNOSIS IS MADE
  • Clinical examination and imaging (e.g. CT) tell us where it is – this is STAGING
  • Describes the location and extent of the disease
  • Gives information about prognosis
  • Sometimes influences treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where does lymphoproliferative disorders occur?

Malignant counterpart of plasma cells is a myeloma

A

ALL is typically a bone marrow disease

Plasma cells that release antibody tend to go back to bone marrow and take-up room

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are hodgkin and on-hodgkin lymphomas?

A

Hodgkin lymphoma is a specific disease

Non-Hodgkin lymphoma is everything else (~ 70 subtypes)

Therefore, non-Hodgkin lymphoma is a broad term! (NHL is not as helpful)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the different Lymphoproliferative disorders?

A

•Non-Hodgkin lymphoma (NHL)

  • High-grade (diffuse large B-cell lymphoma)
  • Low-grade (e.g. follicular, marginal zone)
  • Chronic lymphocytic leukaemia (CLL)
  • Hodgkin lymphoma
  • Acute lymphoblastic leukaemia (ALL)

NHL is the commonest lymphoma and the commonest of that is diffuse large B-cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is Acute lymphoblastic leukaemia (ALL)? (leasst common)

A

•Cancerous disorder of lymphoid progenitor cells

  • Normal = Immature, rapidly proliferating cells that differentiate into lymphocytes
  • Leukaemia = No differentiation. Instead, rapid, uncontrolled growth and accumulation
  • Usually in bone marrow but they can go anywhere

Minimal differentiation and maturation. Fill up bone marrow very quickly

Typically see it arise in bone marrow but can arise anywhere so can behave in funny ways as it is a blood cell and can move anywhere in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the epidemiology of Acute lymphoblastic leukaemia?

A
  • Incidence 1-2/100,000 population/year
  • 75% cases occur in children < 6 years
  • 75-90% cases are of B-cell lineage (You do get T cell ALL)
  • Present with 2-3 week history of bone marrow failure or bone/joint pain (short history)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Typical ALL case history:

  • 17yo male
  • 1 month impaired vision (both eyes)
  • 1/2 stone weight loss (mild weight loss)
  • breathless on minimal exertion

Retinal haemorrhages - Often a source of presentation for some haematological presentations

A

•Investigations:

  • Haemoglobin 38 g/L (120-140)
  • White cell count 370 x 109/L (4-11)
  • Platelets 68 x 109/L (150-400)

• Bone marrow - 90% B-lymphoblasts (almost full of B lymphoblasts so B-cell ALL)

Profoundly anaemic – coping well as young guy

Very marked leucocytosis (white cell count baove normal range)

Thrombocytopenia (low levels of platelets)

Almost certain its an acute leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALL: marrow

what does bone marrow look like in ALL?

A

Left is normal bone marrow – white fatty lumps, mixed with normal blood cells

Megakaryocytes = make platelets

Nice spread of different cells

Right is full of purple stuff so filled with cells, markedly hypercellular

All pretty much the same cells

Pink is bony trabeculae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the characteristics of ALL cells?

A
  • Large cells - Big large abnormal cells. Very primitive and immature
  • Express CD19 – all B-cells have this
  • CD34, TDT – markers of very early, immature cells
  • Not much else – they have not had the chance to develop and mature

Can do immunophenotyping to tell the difference and this can measure if there is things found to it, can tell what m arkers these cells are carrying

May get clues to what type of leukaemia it is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the treatment of ALL?

A

•Standard treatment

  • Induction chemotherapy to obtain remission - Give multiagent combination chemotherapy to obtain a remission which is killing off the leukaemia and allowing normal bone marrow to come back in – this is quite easy to achieve in ALL but we need to give a lot more therapy to stop it coming back
  • Consolidation therapy - Prolonged consolidation therapy
  • CNS directed treatment - High risk of acute leukaemia’s or high grade leukaemia’s or lymphomas involving the CNS
  • Maintenance treatment for 18 months

•Stem cell transplantation (if high risk) - If you have a high risk case and you think the risk of relapse is significant then we would do a transplant but it has its own risks so balance that against the risk of relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are some newer therapies for treating ALL?

A

1) Bi-specifc T-cell engagers (BiTe molecules) – e.g. Blinatumumab

Directing the patients own immune system to kill the cells

Binds to tumour cells and also T cells

2) CAR (chimeric antigen receptor T-cells)

  • Patient/healthy 3rd party T-cells harvested
  • Transfected to express a specific T-cell receptor expressed on leukaemia cells (CD19)
  • Expanded in vitro
  • Re-infused into patient

Taken patient own T cells out. Train T cell to express specific T cell receptor against the CD19 marker and then grown up in the lab and then reinfused to the patient

A bit more like a transplant. Very effective, curative. Very expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are some key side effects with T-cell immunotherapy?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are some ALL poor risk factors?

A
  • Increasing age (As you get older risk of relapse goes up)
  • Increased white cell count (at presentation does worse)
  • Cytogenetics/molecular genetics - t(9;22); t(4;11)
  • Slow/poor response to treatment (measure how deeply the leukemia is responding)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the outcome of ALL?

A

•Adults with ALL:

  • complete remission rate ~90%
  • leukaemia-free survival at 5y 30–35%

•Children with ALL

  • 5y overall survival ~90%
  • Poor risk patients (slow response to induction or Philadelphia positive) 5y OS 45%

Children have a great outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ALL: summary

what is the typical presentation?

and how is it treated?

A

•Typical presentation:

  • Bone marrow failure +/- raised white cell count
  • Bone pain, infection, sweats

(Bone marrow failure = low counts or raised WCC – not mandatory)

•Treated with multi-agent intensive chemotherapy +/- allogeneic stem cell transplant

Biiopsy is key in diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

where do lymphomas/CLL occur?

These cell starting to move out of bone marrow and into secondary lymphoid tissues

A

Most lymphomas are B-cell lymphomas

Due to germinal centre = where B cells encounter antigen

20
Q

how is the CLL diagnosis made?

A
  • Although the term “leukaemia” is used, it is very different to ALL
  • Unlike ALL, the abnormal cells are mature - they usually resemble normal, well-behaved lymphocytes:
  • Grow slowly (or not at all)
  • Classic example of a low-grade condition
  • Carry many of the normal markers that B lymphocytes have

•Requires a lymphocyte count of > 5 (normal is < 4)

21
Q

what is the incidence of CLL?

A
  • > 1700 new cases CLL per year in the UK
  • Commonest leukaemia worldwide
  • 2 males: 1 female
  • Occasionally familial
  • Rare in far East – this likely indicates a Geographic/ ethnic role in pathogenesis

Most dont die with it, they live with it for long periods

22
Q

how does CLL present?

A
  • Often assymptomatic at presentation (Often picked up through routine annual blood check. Often completely fine when you first meet them)
  • Frequent findings:
  • Bone marrow failure (anaemia, thrombocytopenia)
  • Lymphadenopathy
  • Splenomegaly (30%) (As blood cells they can be found in different places)
  • Fever and sweats (< 25%)

•Less common findings:

  • Hepatomegaly
  • Infections
  • weight loss
23
Q

what are some CLL associated findings?

A
  • Immune paresis (loss of normal immunoglobulin production)
  • Haemolytic anaemia
  • 20% have positive direct antiglobulin test
  • 8% clinical evidence of haemolytic anaemia
24
Q

what is the name used for CLL Staging?

A

Binet

25
Q

What is Binet staging for CLL?

A

Idea of how extensive the disease is

Stage it by do they have abnormal blood count, do they have enlarged lymph glands

26
Q

what are the indications for treatment in CLL?

A
  • Progressive bone marrow failure (becoming anaemic)
  • Massive lymphadenopathy
  • Progressive splenomegaly
  • Lymphocyte doubling time <6 months or >50% increase over 2 months
  • Systemic symptoms
  • Autoimmune cytopenias
27
Q

CLL:

It’s a ___ grade disorder

___ curable

A

low

Not

28
Q

what is the treatment of CLL?

A
  • Often nothing – “watch and wait”
  • Cytotoxic chemotherapy e.g. fludarabine, bendamustine (drugs that kill growing cells)
  • Monoclonal antibodies e.g. Rituximab, obinatuzumab (target B cell markers)
  • Novel agents (target specific pathways):
  • Bruton tyrosine kinase inhibitor eg ibrutinib
  • PI3K inhibitor eg idelalisib
  • BCL-2 inhibitor eg venetoclax
29
Q

what are some poor prognostic markers in CLL?

A
  • Advanced disease (Binet stage B or C)
  • Atypical lymphocyte morphology
  • Rapid lymphocyte doubling time (<12 mth)
  • CD 38+ expression
  • Loss/mutation p53; del 11q23 (ATM gene) (if they have bad genetics)
  • Unmutated IgVH gene status
30
Q

what is the presentation of a lymphoma?

A

lymphadenopathy/ hepatosplenomegaly (enlarged as that’s where these cells live)

Extranodal disease (these cells can move anywhere)

“B symptoms”

bone marrow involvement

31
Q

how is the assessment (“staging”) of lymphomas done?

A

lymph node biopsy/ CT scan/ bone marrow aspirate and trephine

32
Q

what are the different stages of a lyphoma?

A

A: absence of B symptoms

B: fever, night sweats, weight loss

3 is above and below the diaphragm

  1. Any extra nodal disease involvement then you automatically have stage 4
33
Q

where do lymphomas occur?

A
34
Q

how are non-hodgkin lymphomas classified?

A

lineage (B-cell or T-cell) - Majority are B-cell in origin (90%)

”Grade” - High-grade vs low-grade

Everything that is not Hodgkin lymphoma

35
Q

what are the different grades of Non-Hodgkin lymphoma and what are they like?

A

Low grade lymphoma:

  • Indolent, often asymptomatic
  • responds to chemotherapy but incurable

grow quite slowly, variation between patients

High grade lymphoma:

  • Aggressive, fast-growing
  • Require combination chemotherapy
  • Can be cured

similarities with ALL as they are aggressive fast growing diseases that require combination chemotherapies and they can both be cured. Distinction is in the name depending on where it presents

36
Q

what are some Specific disease entities of non-hodgkin lymphomas? and what is the treatment?

A

Diffuse large B-cell lymphoma (commonest high grade lymphoma):

  • Commonest subtype of lymphoma (of any kind)
  • High-grade lymphoma

Follicular lymphoma:

  • 2nd commonest subtype of lymphoma
  • Low-grade lymphoma (commonest low grade lymphoma)
  • Like CLL, leave alone if not causing problems – “watch and wait”
  • Both are treated with combination chemotherapy – typically anti-CD20 (marker expressed on mature B cells) monoclonal antibody + chemo

Both of these lymphomas arise from a transformation of the the germinal centre of a lymph node

37
Q

what is the epidemiology of hodgkin lymphoma (More specific entity)?

A

30% of all lymphomas

bimodal age curve:

  • 1st peak at 15-35y
  • 2nd peak later in life

1.9 males: 1 female

association with Epstein Barr virus; familial and geographical clustering

Familial link

Also geographical variation suggesting there is both genetic and environmental factors

38
Q

what is the treatment of Hodgkin lymphoma?

Very treatable condition

A

Combination chemotherapy (ABVD – each letter stands for a different drug) - Typically a combination of chemotherapy drugs used

+/- radiotherapy

Monoclonal antibodies (anti-CD30)

Immunotherapy (checkpoint inhibitors - they switch of inhibitory pathways that allows the immune system to go in and kill these cells)

PET scanning central to assessment of response to treatment

39
Q

Quiz

A

Brain and bladder is normal for the glucose that has been injected

40
Q
A

Asymmetric

Follicular uncommon in this age group

Inflammatory picture, with anaemia and raised CRP coupled with the age group makes 4 most likely

41
Q
A

No extra nodal disease, no bone marrow involvement

42
Q
A

Will grow back if you cut it out

Cytotoxic, combination chemotherapy tends to be the main stay

43
Q
A
44
Q
A

Biopsy is critical

45
Q
A

Cd20 so know they are mature

Not immature

CD5 helps us distinguish certain low grade lymphomas

This is a Low grade mature B cell lymphoma

46
Q
A
  1. this is high grade so large aggressive cells so not this
  2. Not myeloma as not plasma cells
47
Q
A

Nodal disease above and below diaphragm

And since it is in bone marrow it is extra nodal so automatically stage 4

Form the cases the most important thing is the biopsy